VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 106 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $29,007,909 | -22.5% | 1,890,998 | +20.1% | 0.01% | -20.0% |
Q2 2023 | $37,452,645 | +18.3% | 1,574,302 | +26.5% | 0.02% | +7.1% |
Q1 2023 | $31,651,176 | +17.3% | 1,244,150 | +34.7% | 0.01% | +16.7% |
Q4 2022 | $26,985,162 | +4520.7% | 923,833 | +1730.1% | 0.01% | – |
Q2 2022 | $584,000 | – | 50,479 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,696,340 | $55,302,000 | 8.89% |
TCG Crossover Management, LLC | 1,164,000 | $23,874,000 | 7.16% |
VR Adviser, LLC | 2,130,308 | $43,693,000 | 6.74% |
Fairmount Funds Management LLC | 1,369,623 | $28,091,000 | 4.94% |
Paradigm Biocapital Advisors LP | 1,636,211 | $33,559,000 | 4.47% |
Kynam Capital Management, LP | 1,000,000 | $20,510,000 | 4.32% |
Vivo Capital, LLC | 1,660,019 | $34,047,000 | 3.76% |
ACUTA CAPITAL PARTNERS, LLC | 362,735 | $7,440,000 | 3.20% |
Ghost Tree Capital, LLC | 535,000 | $10,973,000 | 3.08% |
Logos Global Management LP | 1,000,000 | $20,510,000 | 2.52% |